CS/HB 733, the Department of Health omnibus for the 2026 session, is one of those bills that defies easy summary — and that is precisely what makes it consequential. Spanning medical marijuana treatment center siting requirements, dental student loan repayment reform, early intervention program administration, emergency license suspensions for practitioners arrested for murder, a new neurofibromatosis research grant program, and revisions to marriage prohibitions, the bill illustrates how even broadly supported omnibus legislation can die a procedural death while the Capitol's attention is fixed on higher-profile fights. The bill passed the House 84-24 on March 4 and the Senate 37-0 on March 12, but ultimately died in messages when the House failed to concur with the Senate's amendments before the session adjourned sine die on March 14.
Medical Marijuana Treatment Center Siting: A New Regulatory Framework
The most commercially significant provisions in HB 733 involve revisions to Section 381.986, Florida Statutes — the core regulatory framework governing medical marijuana treatment centers (MMTCs). The bill introduces new distance requirements that would prohibit MMTC cultivating, processing, and dispensing facilities from operating within specified distances of parks, child care facilities, and early learning facilities. These buffer zone requirements represent a meaningful expansion of local land-use considerations in an industry that has historically operated under a state-dominated regulatory model.
The siting restrictions carry immediate implications for operators planning new locations and for the real estate dynamics surrounding existing facilities. However, the bill includes two important counterweights. First, local governments — counties and municipalities — retain the ability to approve dispensaries within the buffer zones under certain circumstances, preserving a degree of local flexibility that industry stakeholders had lobbied for. Second, a grandfathering provision protects facilities approved before the effective date, and critically, the subsequent establishment of parks, schools, or child care facilities near existing MMTCs does not retroactively affect those operations. This bidirectional grandfathering is a notable concession that prevents the scenario operators most feared: having a legally operating facility rendered noncompliant by a zoning decision they had no part in.
The bill also revises the definition of "low-THC cannabis" to specify 0.8 percent or less THC and at least 2 percent CBD by weight, dispensed exclusively from a licensed MMTC. This definitional tightening aligns Florida's low-THC framework more precisely with emerging national standards and closes potential gaps that had concerned regulators. Additionally, the bill updates physician and medical director qualification and approval requirements for MMTCs, part of a broader effort to strengthen clinical oversight in an industry where the pace of commercial expansion has sometimes outstripped the regulatory infrastructure.
Dental Student Loan Repayment Reform: Broadening Access to Workforce Incentives
Less headline-grabbing but potentially more impactful for underserved communities is the bill's overhaul of the dental student loan repayment program under Section 381.4019, Florida Statutes. The existing program was designed to attract dentists and dental hygienists to areas with inadequate dental care, but its eligibility criteria had been criticized as too narrow and too dependent on outdated geographic designations.
HB 733 addresses these concerns on multiple fronts. The bill redefines "dental health professional shortage area" to align with federal Health Resources and Services Administration (HRSA) designations, replacing Florida-specific definitions that had created confusion and administrative burden. It introduces a "low-income" definition cross-referencing Section 766.1115(3)(e), Florida Statutes, and deletes the previous "medically underserved area" definition entirely. The practical effect is to broaden eligibility significantly: dentists and dental hygienists serving low-income patients — not just those enrolled in Medicaid — now qualify for loan repayment assistance.
This expansion matters because the Medicaid-only eligibility requirement had excluded practitioners who served substantial numbers of low-income patients through charity care, sliding-scale fee arrangements, or community health center models that did not exclusively rely on Medicaid reimbursement. The bill also expands the volunteer service requirements to include Board of Dentistry-approved pro bono programs and state volunteer programs under Part IV of Chapter 110, Florida Statutes, creating additional pathways for practitioners to fulfill program obligations while increasing the supply of free dental care.
For dental workforce advocates, the reforms represent the most significant update to Florida's dental loan repayment incentive structure in over a decade. The alignment with federal HRSA designations also simplifies administration by creating a single, nationally recognized standard for shortage area identification.
Early Steps Program: Administrative Refinements with Real Consequences
The bill revises the Department of Health's duties in administering the Early Steps program — Florida's early intervention system for infants and toddlers with developmental delays — under Sections 391.308 and 391.3081, Florida Statutes. While these changes are largely administrative and conforming in nature, they address an important transition point: the handoff from Early Steps services to school district programs when children age out of the early intervention system.
Updated transition provisions aim to reduce gaps in service delivery during this critical developmental window. Parents and advocacy groups have long flagged the Early Steps-to-school transition as a point of vulnerability where children can lose access to therapies and support services for weeks or months. The bill's conforming changes also extend to the Early Steps Extended Option, ensuring consistency across the program's various service delivery pathways.
Emergency License Suspension: Murder Arrests Trigger Immediate Action
Among the bill's more striking provisions is an amendment to Section 456.074, Florida Statutes, requiring the Department of Health to issue an emergency suspension order for any health care practitioner arrested for committing, attempting, soliciting, or conspiring to commit murder — whether the arrest occurs in Florida or another jurisdiction. This provision eliminates the discretion that previously existed in the emergency suspension process for these cases, making the suspension order automatic upon arrest.
The policy rationale is straightforward: a licensed health care practitioner arrested for murder poses an immediate public safety concern that warrants suspension before adjudication. The extension to out-of-state arrests reflects the reality that practitioners may hold licenses in multiple states and that criminal conduct in one jurisdiction should trigger protective action in all jurisdictions where the individual is authorized to practice. The provision is narrowly tailored to murder-related charges, distinguishing it from broader proposals that have sought automatic suspension for a wider range of felony arrests.
Neurofibromatosis Research: A New Grant Program
Added during the committee process, the bill creates a grant program within the Department of Health dedicated to neurofibromatosis research. Neurofibromatosis is a group of genetic disorders that cause tumors to form on nerve tissue, affecting approximately one in 3,000 births. Despite its prevalence, neurofibromatosis has historically been underfunded relative to other genetic disorders, and patient advocacy groups have pressed state legislatures to supplement the limited federal research pipeline.
The creation of a state-level grant program follows the model established by Florida's existing disease-specific research programs, including those for cancer, cardiovascular disease, and spinal cord injury. While the bill establishes the programmatic framework, the actual funding level will be determined through the appropriations process — a distinction that patient advocates understand well. The authorization is necessary but not sufficient; securing a meaningful appropriation in future budget cycles will determine whether the program delivers tangible research outcomes.
Additional Provisions: Marriage Prohibitions and Autism Training
Two additional provisions, both added during the committee process, round out the bill's scope. The first establishes prohibitions on marriage between certain related individuals, a family law provision that was grafted onto the health omnibus during the amendment process. The second revises micro-credential component requirements for the University of Florida Center for Autism and Neurodevelopment under Section 1004.551, Florida Statutes, updating the specialized training framework that supports professionals working with individuals on the autism spectrum.
Legislative Path and Procedural Status
HB 733's journey through the Legislature was relatively smooth for a bill of its complexity. Filed on December 10, 2025, and sponsored by the Health & Human Services Committee with Rep. Gerwig as the lead, the bill moved through three House committee stops — Health Professions & Programs Subcommittee, Health Care Budget Subcommittee, and the full Health & Human Services Committee — receiving favorable reports at each stage. The full committee adopted a committee substitute on February 24, 2026, incorporating the various additions and refinements that had accumulated during the process.
On the House floor, the bill passed 84-24 on March 4 with three floor amendments adopted (Amendments 268207, 606985, and 872191). The 24 nay votes — a notable minority for a departmental omnibus — likely reflected concerns about specific provisions rather than opposition to the bill as a whole, with the medical marijuana siting requirements and the marriage prohibition provisions the most probable sources of dissent.
The Senate's handling was procedurally distinctive. Rather than moving the companion bill (CS/CS/CS/SB 902, filed by Sen. Garcia) through its remaining committee stops, the Senate withdrew SB 902 from the Rules Committee, substituted HB 733 in its place, adopted Amendment 296444, and passed the amended bill unanimously, 37-0. This substitution procedure, while common for companion bills late in session, means the version that passed the Senate differs from the version that passed the House.
CS/HB 733 died in messages on March 14, 2026, when the regular session adjourned sine die without the House concurring with the Senate's amendments. Despite passing both chambers — the House 84-24 and the Senate unanimously at 37-0 — the bill was never engrossed or enrolled. None of its provisions will take effect. The policies it carried, from MMTC siting requirements to the neurofibromatosis grant program, will need to be refiled in a future session. Given the overwhelming bipartisan support, government affairs professionals should expect these provisions to resurface.
What It Means for Stakeholders
The bill's death means none of its provisions will take effect. For medical marijuana operators, the proposed siting requirements are off the table — for now. Facility planning can proceed without the new buffer zone restrictions, though operators should anticipate these provisions resurfacing in a future session given the unanimous Senate support. For dental workforce organizations and community health centers, the loan repayment reforms that would have broadened eligibility beyond Medicaid-only patients will need a new legislative vehicle. For neurofibromatosis patients and researchers, the grant program authorization that took years of advocacy to secure must start the process again. And for the healthcare regulatory community, the automatic license suspension provision for murder arrests remains uncodified.
HB 733 is, in many ways, the quintessential omnibus casualty — a vehicle whose individual provisions commanded broad bipartisan support but whose procedural fate was sealed by the clock. The bill passed each chamber by comfortable margins, yet none of it became law. For government affairs professionals tracking Florida health policy, the question is not whether these provisions return but in what form and on what vehicle. Given that the bill passed the Senate 37-0, the policy substance is not in dispute. The process failed the policy. Expect these provisions to be refiled — likely as early as the 2027 session or in any intervening special session.